Citation: G. Wensing, PHASE-I STUDIES IN PATIENTS WITH LIVER-CIRRHOSIS, International journal of clinical pharmacology and therapeutics, 36(11), 1998, pp. 599-603
Authors:
BREITHAUPTGROGLER K
MALERCZYK C
BELZ GG
BUTZER R
HERRMANN V
STASS H
WENSING G
Citation: K. Breithauptgrogler et al., PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES OF AN ANGIOTENSIN-II RECEPTOR ANTAGONIST - CHARACTERIZATION BY USE OF SCHILD REGRESSION TECHNIQUE IN MAN, International journal of clinical pharmacology and therapeutics, 35(10), 1997, pp. 434-441
Authors:
WENSING G
LOTTERER E
LINK I
HAHN EG
FLEIG WE
Citation: G. Wensing et al., URINARY SODIUM-BALANCE IN PATIENTS WITH CIRRHOSIS - RELATIONSHIP TO QUANTITATIVE PARAMETERS OF LIVER-FUNCTION, Hepatology, 26(5), 1997, pp. 1149-1155
Citation: G. Wensing et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF BAY-X-7195 AEROSOL, A NEW AND SELECTIVE RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, IN NORMAL VOLUNTEERS, British journal of clinical pharmacology, 42(2), 1996, pp. 171-178
Authors:
HEINIG R
SCHAEFER HG
WENSING G
KUHLMANN J
Citation: R. Heinig et al., PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE ORALLY-ADMINISTERED RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES BAY-X-7195 IN SINGLE-DOSE ESCALATION STUDIES, International journal of clinical pharmacology and therapeutics, 33(10), 1995, pp. 573-579
Authors:
WENSING G
LOTTERER E
AHLSDORF H
KUGLER CFA
HAHN EG
FLEIG WE
Citation: G. Wensing et al., RELATIONSHIP OF THE AMINOPYRINE BREATH TEST AND THE CHILD-PUGH SCORE TO URINARY SODIUM RETENTION IN PATIENTS WITH LIVER-CIRRHOSIS, Zeitschrift fur Gastroenterologie, 33(3), 1995, pp. 150-154
Citation: G. Wensing et al., RELATIONSHIP BETWEEN OXIDATIVE HEPATIC-METABOLISM, URINARY SODIUM-EXCRETION AND SYMPATHETIC-NERVE ACTIVITY IN EXPERIMENTAL CIRRHOSIS IN THERAT, Zeitschrift fur Gastroenterologie, 33(1), 1995, pp. 1-4
Authors:
WENSING G
HEINIG R
PRIESNITZ M
KUHLMANN J
Citation: G. Wensing et al., EFFECT OF BAY-X-7195, AN ORAL RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, ON LEUKOTRIENE-D-4 INDUCED BRONCHOCONSTRICTION IN NORMAL VOLUNTEERS, European Journal of Clinical Pharmacology, 47(3), 1994, pp. 227-230
Authors:
WENSING G
HEINIG R
PRIESNITZ M
KUHLMANN J
Citation: G. Wensing et al., EFFECT OF BAY-X-7195, AN ORAL RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, ON LEUKOTRIENE-D-4 INDUCED BRONCHOCONSTRICTION IN NORMAL VOLUNTEERS, European Journal of Clinical Pharmacology, 47(3), 1994, pp. 227-230
Authors:
KUGLER CFA
PETTER J
TAGHAVY A
LOTTERER E
WENSING G
HAHN EG
FLEIG WE
Citation: Cfa. Kugler et al., DYNAMICS OF COGNITIVE BRAIN-DYSFUNCTION IN PATIENTS WITH CIRRHOTIC LIVER-DISEASE - AN EVENT-RELATED P300 POTENTIAL PERSPECTIVE, Electroencephalography and clinical neurophysiology, 91(1), 1994, pp. 33-41
Citation: G. Wensing et al., EFFECT OF THE LEUKOTRIENE D-4 (LTD(4))-RECEPTOR ANTAGONIST BAY X 7195ON LTD(4)-INDUCED BRONCHOCONSTRICTION IN NORMAL SUBJECTS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 203-203
Authors:
WENSING G
LOTTERER E
DISTLER O
GALLER A
HAHN EG
FLEIG WE
Citation: G. Wensing et al., HEPATIC ENZYME-INDUCTION PREVENTS RENAL SODIUM RETENTION IN PARTIALLYPORTAL-VEIN LIGATED RATS, Hepatology, 18(4), 1993, pp. 10000293-10000293